HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomasAngela Sosin, Ayad Al‐Katib|Journal of Hematology & Oncology|2012Cited by 37
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation statusAyad Al‐Katib, Ramzi M. Mohammad|Journal of Hematology & Oncology|2009Cited by 32